Constructing an Intelligent Model Based on Support Vector Regression to Simulate the Solubility of Drugs in Polymeric Media.

drug kernel type polymer solubility temperature support vector regression tuning techniques

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
14 Nov 2022
Historique:
received: 10 09 2022
revised: 30 10 2022
accepted: 01 11 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

This study constructs a machine learning method to simultaneously analyze the thermodynamic behavior of many polymer-drug systems. The solubility temperature of Acetaminophen, Celecoxib, Chloramphenicol, D-Mannitol, Felodipine, Ibuprofen, Ibuprofen Sodium, Indomethacin, Itraconazole, Naproxen, Nifedipine, Paracetamol, Sulfadiazine, Sulfadimidine, Sulfamerazine, and Sulfathiazole in 1,3-bis[2-pyrrolidone-1-yl] butane, Polyvinyl Acetate, Polyvinylpyrrolidone (PVP), PVP K12, PVP K15, PVP K17, PVP K25, PVP/VA, PVP/VA 335, PVP/VA 535, PVP/VA 635, PVP/VA 735, Soluplus analyzes from a modeling perspective. The least-squares support vector regression (LS-SVR) designs to approximate the solubility temperature of drugs in polymers from polymer and drug types and drug loading in polymers. The structure of this machine learning model is well-tuned by conducting trial and error on the kernel type (i.e., Gaussian, polynomial, and linear) and methods used for adjusting the LS-SVR coefficients (i.e., leave-one-out and 10-fold cross-validation scenarios). Results of the sensitivity analysis showed that the Gaussian kernel and 10-fold cross-validation is the best candidate for developing an LS-SVR for the given task. The built model yielded results consistent with 278 experimental samples reported in the literature. Indeed, the mean absolute relative deviation percent of 8.35 and 7.25 is achieved in the training and testing stages, respectively. The performance on the largest available dataset confirms its applicability. Such a reliable tool is essential for monitoring polymer-drug systems' stability and deliverability, especially for poorly soluble drugs in polymers, which can be further validated by adopting it to an actual implementation in the future.

Identifiants

pubmed: 36422535
pii: ph15111405
doi: 10.3390/ph15111405
pmc: PMC9696511
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Mol Pharm. 2015 Sep 8;12(9):3408-19
pubmed: 26214347
J Pharm Sci. 2010 Sep;99(9):4023-31
pubmed: 20607809
Nat Commun. 2021 Jun 8;12(1):3428
pubmed: 34103526
Front Mol Biosci. 2022 Feb 14;9:845179
pubmed: 35237665
Pharm Res. 2009 Apr;26(4):855-64
pubmed: 19052850
Ther Deliv. 2015 Feb;6(2):247-61
pubmed: 25690090
J Adv Res. 2022 Jun 3;:
pubmed: 35667548
World J Gastroenterol. 2022 Jul 14;28(26):3092-3100
pubmed: 36051346
J Pharm Sci. 2021 Jul;110(7):2703-2717
pubmed: 33609521
Circulation. 2017 May 2;135(18):1733-1748
pubmed: 28302752
Eur J Pharm Sci. 2015 Apr 25;71:12-24
pubmed: 25686597
Drug Discov Today Technol. 2012 Summer;9(2):e71-e174
pubmed: 24064267
J Pharm Sci. 2016 Sep;105(9):2621-2624
pubmed: 27012222
J Pharm Sci. 2015 Jan;104(1):44-51
pubmed: 25363890
Polymers (Basel). 2022 Jan 28;14(3):
pubmed: 35160516
Drug Deliv. 2020 Dec;27(1):110-127
pubmed: 31885288
Pharm Res. 2016 Oct;33(10):2445-58
pubmed: 27283830
J Pharm Sci. 2014 Sep;103(9):2847-2858
pubmed: 24634063
Pharmaceutics. 2020 May 27;12(6):
pubmed: 32471023
Pharmaceutics. 2020 Aug 02;12(8):
pubmed: 32748814
Int J Pharm. 2020 Oct 15;588:119741
pubmed: 32783978
Cancer Res. 2020 Jan 15;80(2):319-333
pubmed: 31690668
Int J Pharm. 2018 Mar 1;538(1-2):1-13
pubmed: 29278733
Eur J Pharm Sci. 2015 Sep 18;77:106-11
pubmed: 26006307
Front Immunol. 2022 Aug 29;13:988326
pubmed: 36105818
Sci Rep. 2022 Jun 7;12(1):9380
pubmed: 35672349
Eur Radiol. 2022 Jan;32(1):702-713
pubmed: 34255160
AAPS PharmSciTech. 2013 Mar;14(1):464-74
pubmed: 23389838
Pharm Res. 2009 Nov;26(11):2523-34
pubmed: 19771495
Bioconjug Chem. 2018 Apr 18;29(4):939-952
pubmed: 29319295
Cell Rep. 2021 Oct 12;37(2):109821
pubmed: 34644569
J Control Release. 2017 Sep 28;262:329-347
pubmed: 28778479
Int J Pharm Investig. 2012 Jan;2(1):12-7
pubmed: 23071955
Eur J Pharm Biopharm. 2019 Apr;137:227-232
pubmed: 30836180

Auteurs

Sait Senceroglu (S)

Faculty of Pharmacy, Ege University, Izmir 35040, Turkey.

Mohamed Arselene Ayari (MA)

Department of Civil and Architectural Engineering, Qatar University, Doha 2713, Qatar.
Technology Innovation and Engineering Education Unit (TIEE), Qatar University, Doha 2713, Qatar.

Tahereh Rezaei (T)

Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz 71348, Iran.

Fardad Faress (F)

Department of Business, Data Analysis, The University of Texas Rio Grande Valley (UTRGV), Edinburg, TX 78539, USA.

Amith Khandakar (A)

Department of Electrical Engineering, Qatar University, Doha 2713, Qatar.

Muhammad E H Chowdhury (MEH)

Department of Electrical Engineering, Qatar University, Doha 2713, Qatar.

Zanko Hassan Jawhar (ZH)

Department of Medical Laboratory Science, College of Health Science, Lebanese French University, Erbil 44001, Kurdistan Region, Iraq.

Classifications MeSH